EVENT

Photonic Diagnosis, Monitoring, Prevention, and Treatment of Infections and Inflammatory Diseases Meeting

San Francisco, USAFebruary 2 - 7, 2019

Find out how to make a difference in wound care

MolecuLight Headquarters

425 University Avenue
Suite 700
Toronto, ON M5G 1T6
Canada

US Address
MolecuLight Corp.
2403 Sidney Street,
Suite 209
Pittsburgh, PA 15203

T. +1 647-362-4684
North American Toll Free:
1-877-818-4360
F.+1 647-362-4730
E: info@moleculight.com

Sitemap

MolecuLight DX Device
MolecuLight i:X
MolecuLight i:X Case Studies
Publications
MolecuLight Posters
Clinical Image Gallery of Fluorescence Images

Reimbursement
Training Resources
Webcast Recordings
Wound Care VIDEO MASTER SERIES
MolecuLightDX Training Videos
User Documentation for the MolecuLight i:X
Frequently Asked Questions (FAQ)

MolecuLight Executive Team
MolecuLight Conferences & Events
MolecuLight Press Releases

Contact MolecuLight
Distributors
MolecuLight Careers

MolecuLight is SOC ll^®
Type l Accredited:

MolecuLight awarded
Premier’s Technology
Breakthrough Designation

MolecuLight i:X
is designated as a:

MolecuLight included
in ISWCAP Consensus
Guidelines:

MolecuLight is a proud
corporate member of:

Global

USA

©2024
The MolecuLight® i:X and MolecuLightDX™ Imaging Devices are approved by Health Canada for sale in Canada and has CE marking for sale in the European Union.
The MolecuLight™ i:X and DX Imaging Devices have received FDA clearance.